Global Cardioverter Defibrillator Device Market Size, Share, and COVID-19 Impact Analysis, By Type (Implantable Cardioverter Defibrillators, and External Cardioverter Defibrillators), By End User (Hospitals, Pre-Hospital, Public Access Market, Alternative Care, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035.

Global Cardioverter Defibrillator Device Market Insights Forecasts to 2035

• The Global Cardioverter Defibrillator Device Market Size Was Estimated at USD 16.18 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.96% from 2025 to 2035
• The Worldwide Cardioverter Defibrillator Device Market Size is Expected to Reach USD 33.90 Billion by 2035
• Asia Pacific is expected to Grow the fastest during the forecast period.

The Global Cardioverter Defibrillator Device Market Size was worth around USD 16.18 Billion in 2024 and is predicted to Grow to around USD 33.90 Billion by 2035 with a compound annual growth rate (CAGR) of 6.96% from 2025 and 2035. The cardioverter defibrillator device market has opportunities in wearable defibrillators, AI-driven remote monitoring, growing access to healthcare in developing nations, technological advancements, government healthcare programs, and strategic alliances to improve cardiac care options.    

Market Overview

The global industry that produces, distributes, and develops medical devices intended to identify and treat potentially fatal cardiac arrhythmias is known as the cardioverter defibrillator device market. In order to prevent sudden cardiac arrest (SCA), these devices, which fall into two categories, external cardioverter defibrillators (ECDs) and implantable cardioverter defibrillators (ICDs), deliver controlled electrical shocks to restore normal heart rhythm. The creation, manufacturing, and distribution of medical devices intended to monitor, identify, and treat life-threatening cardiac rhythm disorders specifically cardiac arrhythmias and sudden cardiac arrest (SCA), are the main objectives of the cardioverter defibrillator device market. Increased product development, public awareness, the occurrence of sudden cardiac arrest, and government and healthcare organization initiatives are all factors contributing to the cardioverter defibrillator device market.  The rising incidence of heart conditions, such as heart failure and arrhythmias, is anticipated to fuel cardioverter defibrillator device market.    

Report Coverage

This research report categorizes the cardioverter defibrillator device market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the cardioverter defibrillator device market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the cardioverter defibrillator device market. 

Driving Factors

Technological advancements, rising rates of cardiovascular disease, and easier access to healthcare are driving the cardioverter defibrillator device market. The demand for cardioverter defibrillator devices, especially implantable cardioverter defibrillators and external defibrillators, has increased due to the rising prevalence of arrhythmias, sudden cardiac arrest, and heart failure. The need for sophisticated defibrillation techniques is growing as the elderly population becomes more vulnerable to heart conditions. Improved infrastructure and increased healthcare spending are driving cardioverter defibrillator device market expansion.   

Restraining Factors

The market for cardioverter defibrillator device is restricted by factors such high device costs, strict regulatory clearances, low awareness in developing nations, technical issues, reimbursement difficulties, and difficult implantation procedures, all of which hinder market growth.

Market Segmentation

The cardioverter defibrillator device market share is classified into type and end user. 

• The implantable cardioverter defibrillators segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the cardioverter defibrillator device market is divided into implantable cardioverter defibrillators and external cardioverter defibrillators. Among these, the implantable cardioverter defibrillators segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The market for implantable defibrillators is driven by the growing number of elderly people, the introduction of new technology, the growing use of S-ICDs, and the rising incidence of SCA. The portion of the implantable cardioverter defibrillator (ICD) is intended to monitor and control irregular heartbeats in individuals who are susceptible to sudden cardiac arrest (SCA).

• The hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end user, the cardioverter defibrillator device market is divided into hospitals, pre-hospital, public access market, alternative care, and others. Among these, the hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The rise in hospital-admitted cardiac patients and hospital-performed procedures is responsible for the increase of the hospital segment. Hospitals are increasingly using both external defibrillators and ICDs to treat patients who have experienced cardiac arrest.  

Regional Segment Analysis of the Cardioverter Defibrillator Device Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the cardioverter defibrillator device market over the predicted timeframe.

North America is anticipated to hold the largest share of the cardioverter defibrillator device market over the predicted timeframe. North America is the result of important players' activities, advantageous laws, and cutting-edge technology infrastructure in the US and Canada. The region's market share is further reinforced by the presence of top manufacturers like Abbott Laboratories, Boston Scientific, and Medtronic. Demand is still being driven by high levels of awareness, accessibility, and the growth of emergency medical services. In order to maintain leadership in the worldwide industry, the market is anticipated to see ongoing innovation and investment in research & development.

Asia Pacific is expected to grow at a rapid CAGR in the cardioverter defibrillator device market during the forecast period. The growing healthcare infrastructure, large patient base, and high incidence of heart conditions are all factors contributing to the market's expansion. The rapid regional expansion can be attributed to the high defibrillator penetration and favorable legislation in the Japanese market. Technological breakthroughs, rising healthcare investments, and the prevalence of cardiovascular disease are the main drivers of the Asia-Pacific region.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the cardioverter defibrillator device market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Laboratories
• Fukuda Denshi Co.
• Physio-Control
• Defibtech LLC
• Medtronic PLC
• Schiller AG
• Mediana Co., Ltd.
• Koninklijke Philips N.V.
• Stryker Corporation
• BIOTRONIK SE & Co. KG
• Cardiac Science Corporation
• Boston Scientific Corporation
• Zoll Medical Corporation
• Nihon Kohden Corporation
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In June 2020, Premarket approval was presented to ZOLL Medical Corporation, a company within the Asahi Kasei Group, for its ZOLL AED 3 defibrillator, which has wireless connectivity, integrated kid rescue, and improved real CPR assistance.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the cardioverter defibrillator device market based on the below-mentioned segments: 

Global Cardioverter Defibrillator Device Market, By Type

• Implantable Cardioverter Defibrillators
• External Cardioverter Defibrillators

Global Cardioverter Defibrillator Device Market, By End User

• Hospitals
• Pre-Hospital
• Public Access Market
• Alternative Care
• Others

Global Cardioverter Defibrillator Device Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa